WIF-1 Activators
WIF-1 activators represent a diverse group of compounds that modulate key signaling pathways involved in the regulation of WIF-1 expression and activity. These chemicals, such as SB431542 and LY364947, operate by inhibiting the TGF-β type I receptor (ALK5), thereby disrupting TGF-β signaling and potentially indirectly activating WIF-1. Similarly, compounds like LGK974 and ICG-001 interfere with the Wnt pathway, either by inhibiting Wnt ligand secretion or disrupting β-catenin/CBP interaction, contributing to potential WIF-1 activation.
Tankyrase inhibitors like XAV-939 and Wnt pathway inhibitors like PKF118-310 and AMG-44 exert their effects by stabilizing axin or disrupting the interaction between Dishevelled and Frizzled, influencing canonical Wnt signaling and potentially activating WIF-1. Additionally, small molecules like PRI-724 and NSC668036 target the β-catenin/CBP interaction or inhibit Wnt signaling directly, offering alternative routes for WIF-1 activation. These chemicals collectively present a nuanced repertoire of mechanisms through which WIF-1 may be activated. Understanding their specific impacts on signaling pathways provides valuable insights into potential strategies for manipulating WIF-1 activity, contributing to a broader comprehension of Wnt pathway regulation in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a selective inhibitor of TGF-β type I receptor (ALK5). By inhibiting ALK5, SB431542 modulates the TGF-β signaling pathway, potentially leading to the activation of WIF-1. The inhibition of ALK5 by SB431542 disrupts downstream signaling, influencing cellular processes that may indirectly activate WIF-1 by interfering with TGF-β-mediated suppression. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $107.00 $156.00 | 4 | |
LY364947 is another selective TGF-β receptor (ALK5) inhibitor. Similar to SB431542, LY364947 disrupts TGF-β signaling, potentially leading to the activation of WIF-1. Its inhibition of ALK5 influences the cellular environment by altering TGF-β-mediated responses, providing a potential indirect activation mechanism for WIF-1. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a γ-secretase inhibitor that interferes with Notch signaling. By blocking γ-secretase, DAPT disrupts Notch pathway activation, potentially influencing WIF-1. The inhibition of Notch signaling by DAPT may indirectly activate WIF-1 by modulating downstream events in cellular processes. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $180.00 $651.00 | ||
PKF118-310 is a potent and selective inhibitor of the canonical Wnt signaling pathway. Its interference with canonical Wnt signaling may potentially activate WIF-1, as WIF-1 is known to antagonize Wnt signaling. PKF118-310's inhibition of Wnt signaling may indirectly activate WIF-1 by preventing the activation of downstream events in the canonical Wnt pathway. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 is a small molecule inhibitor of Porcupine, a protein involved in Wnt ligand secretion. Its inhibition of Porcupine disrupts Wnt ligand secretion, potentially leading to the activation of WIF-1. The interference with Wnt ligand secretion by IWP-2 may indirectly activate WIF-1 by impacting Wnt-mediated signaling events. | ||||||